摘要 |
Patients susceptible to or suffering from central nervous system disorders (e.g., neurodegenerative diseases including presenile dementia, senile dementia of the Alzheimer's type, and Parkinsonism including Parkinsons's disease, and other CNS disorders including attention deficit disorder, schizophrenia and Tourette's syndrome) are treated by administering an effective amount of 2-azabicyclo [2.2.1] hept-5-ene and 2-azabicyclo [2.2.2] oct-5-ene compounds. Exemplary compounds are (+/-)-3-<u>exo</u> and (+/-)-3-<u>endo</u> forms of 2-methyl-3-(3-pyridyl)-2-azabicyclo[2.2.1]hept-5-ene, (+/-)-3-<u>exo</u> and (+/-)-3-<u>endo</u> forms of 2-methyl-3-(3-pyridyl)-2-azabicyclo[2.2.1]hept-5-ene, (+/-)-3-<u>exo</u> and (+/-)-3-<u>endo</u> forms of 2-benzyl-3-(3-pyridyl)-2-azabicyclo[2.2.1]hept-5-ene, (+/-)-3-<u>exo</u> and (+/-)-3-<u>endo</u> forms of 2-para-anisyl-3-(3-pyridyl)-2-azabicyclo[2.2.1]hept-5-ene, (+/-)-3-<u>exo</u> and (+/-)-3-<u>endo</u> forms of 3-(3-pyridyl)-2-azabicyclo[2.2.2]oct-5-ene, (+/-)-3-<u>exo</u> and (+/-)-3-<u>endo</u> forms of 3-(3-pyridyl)-2-azabicyclo[2.2.2.]oct-5-ene, (+/-)-3-<u>exo</u> and (+/-)-3-<u>endo</u> forms of 2-methyl-3-(3-pyridyl)-2-azabicyclo[2.2.2.]oct-5-ene, the racemic form of 3-(3-pyridyl)-2-azabicyclo[2.2.2]octane, and the racemic form of 2-methyl-3-(3-pyridyl)-2-azabicyclo[2.2.2]octane.
|
申请人 |
R.J. REYNOLDS TOBACCO COMPANY;UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION;BENCHERIF, MEROUANE;CALDWELL, WILLIAM, SCOTT;DULL, GARY, MAURICE;LIPPIELLO, PATRICK, MICHAEL;CROOKS, PETER, ANTHONY;BHATTI, BALWINDER, SINGH;DEO, NIRANJAN, MADHUKAR;RAVARD, ALAIN |
发明人 |
BENCHERIF, MEROUANE;CALDWELL, WILLIAM, SCOTT;DULL, GARY, MAURICE;LIPPIELLO, PATRICK, MICHAEL;CROOKS, PETER, ANTHONY;BHATTI, BALWINDER, SINGH;DEO, NIRANJAN, MADHUKAR;RAVARD, ALAIN |